nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—Parkinson's disease—Rivastigmine—Alzheimer's disease	0.444	1	CpDpCtD
Memantine—GRIN2B—Alzheimer's disease	0.3	1	CbGaD
Memantine—GRIN1—telencephalic ventricle—Alzheimer's disease	0.00521	0.14	CbGeAlD
Memantine—GRIN2B—telencephalic ventricle—Alzheimer's disease	0.00497	0.133	CbGeAlD
Memantine—DRD2—telencephalic ventricle—Alzheimer's disease	0.00176	0.0473	CbGeAlD
Memantine—GRIN3A—forebrain—Alzheimer's disease	0.00144	0.0385	CbGeAlD
Memantine—GRIN1—forebrain—Alzheimer's disease	0.00136	0.0365	CbGeAlD
Memantine—GRIN3A—telencephalon—Alzheimer's disease	0.00132	0.0354	CbGeAlD
Memantine—GRIN2B—forebrain—Alzheimer's disease	0.0013	0.0348	CbGeAlD
Memantine—GRIN1—telencephalon—Alzheimer's disease	0.00125	0.0336	CbGeAlD
Memantine—GRIN2B—telencephalon—Alzheimer's disease	0.00119	0.032	CbGeAlD
Memantine—GRIN2A—forebrain—Alzheimer's disease	0.00113	0.0305	CbGeAlD
Memantine—GRIN2A—telencephalon—Alzheimer's disease	0.00104	0.028	CbGeAlD
Memantine—GRIN3A—nervous system—Alzheimer's disease	0.000779	0.0209	CbGeAlD
Memantine—HTR3A—forebrain—Alzheimer's disease	0.000752	0.0202	CbGeAlD
Memantine—GRIN3A—central nervous system—Alzheimer's disease	0.00075	0.0201	CbGeAlD
Memantine—GRIN1—nervous system—Alzheimer's disease	0.000739	0.0198	CbGeAlD
Memantine—GRIN1—central nervous system—Alzheimer's disease	0.000711	0.0191	CbGeAlD
Memantine—GRIN2B—nervous system—Alzheimer's disease	0.000705	0.0189	CbGeAlD
Memantine—GRIN1—cerebellum—Alzheimer's disease	0.000695	0.0187	CbGeAlD
Memantine—HTR3A—telencephalon—Alzheimer's disease	0.000692	0.0186	CbGeAlD
Memantine—GRIN2B—central nervous system—Alzheimer's disease	0.000678	0.0182	CbGeAlD
Memantine—GRIN2B—cerebellum—Alzheimer's disease	0.000663	0.0178	CbGeAlD
Memantine—GRIN2A—nervous system—Alzheimer's disease	0.000616	0.0165	CbGeAlD
Memantine—GRIN3A—brain—Alzheimer's disease	0.000596	0.016	CbGeAlD
Memantine—GRIN2A—central nervous system—Alzheimer's disease	0.000593	0.0159	CbGeAlD
Memantine—GRIN2A—cerebellum—Alzheimer's disease	0.00058	0.0156	CbGeAlD
Memantine—GRIN1—brain—Alzheimer's disease	0.000565	0.0152	CbGeAlD
Memantine—GRIN2B—brain—Alzheimer's disease	0.000539	0.0145	CbGeAlD
Memantine—GRIN2A—brain—Alzheimer's disease	0.000471	0.0126	CbGeAlD
Memantine—DRD2—forebrain—Alzheimer's disease	0.00046	0.0124	CbGeAlD
Memantine—DRD2—telencephalon—Alzheimer's disease	0.000423	0.0114	CbGeAlD
Memantine—HTR3A—nervous system—Alzheimer's disease	0.000408	0.011	CbGeAlD
Memantine—HTR3A—central nervous system—Alzheimer's disease	0.000393	0.0106	CbGeAlD
Memantine—CYP2A6—cerebellum—Alzheimer's disease	0.000378	0.0101	CbGeAlD
Memantine—HTR3A—brain—Alzheimer's disease	0.000312	0.00838	CbGeAlD
Memantine—CYP2A6—brain—Alzheimer's disease	0.000307	0.00823	CbGeAlD
Memantine—DRD2—nervous system—Alzheimer's disease	0.00025	0.00671	CbGeAlD
Memantine—DRD2—central nervous system—Alzheimer's disease	0.000241	0.00646	CbGeAlD
Memantine—DRD2—cerebellum—Alzheimer's disease	0.000235	0.00631	CbGeAlD
Memantine—CYP2B6—nervous system—Alzheimer's disease	0.000202	0.00542	CbGeAlD
Memantine—CYP2B6—central nervous system—Alzheimer's disease	0.000195	0.00522	CbGeAlD
Memantine—DRD2—brain—Alzheimer's disease	0.000191	0.00513	CbGeAlD
Memantine—CYP2B6—brain—Alzheimer's disease	0.000154	0.00414	CbGeAlD
Memantine—Tension—Galantamine—Alzheimer's disease	0.000109	0.000771	CcSEcCtD
Memantine—Dysgeusia—Galantamine—Alzheimer's disease	0.000109	0.00077	CcSEcCtD
Memantine—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000109	0.000768	CcSEcCtD
Memantine—Renal failure—Donepezil—Alzheimer's disease	0.000109	0.000766	CcSEcCtD
Memantine—Myocardial infarction—Donepezil—Alzheimer's disease	0.000108	0.000764	CcSEcCtD
Memantine—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000108	0.000764	CcSEcCtD
Memantine—Nervousness—Galantamine—Alzheimer's disease	0.000108	0.000763	CcSEcCtD
Memantine—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000108	0.000761	CcSEcCtD
Memantine—Back pain—Galantamine—Alzheimer's disease	0.000108	0.00076	CcSEcCtD
Memantine—Urinary tract infection—Donepezil—Alzheimer's disease	0.000108	0.000758	CcSEcCtD
Memantine—Conjunctivitis—Donepezil—Alzheimer's disease	0.000108	0.000758	CcSEcCtD
Memantine—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000107	0.000756	CcSEcCtD
Memantine—Sweating increased—Rivastigmine—Alzheimer's disease	0.000107	0.000756	CcSEcCtD
Memantine—Bronchitis—Rivastigmine—Alzheimer's disease	0.000106	0.000747	CcSEcCtD
Memantine—Haematuria—Donepezil—Alzheimer's disease	0.000105	0.000743	CcSEcCtD
Memantine—Vision blurred—Galantamine—Alzheimer's disease	0.000105	0.000741	CcSEcCtD
Memantine—Tremor—Galantamine—Alzheimer's disease	0.000104	0.000736	CcSEcCtD
Memantine—Epistaxis—Donepezil—Alzheimer's disease	0.000104	0.000735	CcSEcCtD
Memantine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000103	0.000729	CcSEcCtD
Memantine—Anaemia—Galantamine—Alzheimer's disease	0.000103	0.000726	CcSEcCtD
Memantine—Dysuria—Rivastigmine—Alzheimer's disease	0.000103	0.000726	CcSEcCtD
Memantine—Agitation—Galantamine—Alzheimer's disease	0.000102	0.000722	CcSEcCtD
Memantine—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000102	0.000722	CcSEcCtD
Memantine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000102	0.000717	CcSEcCtD
Memantine—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000101	0.000715	CcSEcCtD
Memantine—Bradycardia—Donepezil—Alzheimer's disease	0.000101	0.000712	CcSEcCtD
Memantine—Malaise—Galantamine—Alzheimer's disease	0.000101	0.000709	CcSEcCtD
Memantine—Weight increased—Rivastigmine—Alzheimer's disease	0.0001	0.000707	CcSEcCtD
Memantine—Vertigo—Galantamine—Alzheimer's disease	0.0001	0.000706	CcSEcCtD
Memantine—Syncope—Galantamine—Alzheimer's disease	0.0001	0.000705	CcSEcCtD
Memantine—Haemoglobin—Donepezil—Alzheimer's disease	9.98e-05	0.000703	CcSEcCtD
Memantine—Weight decreased—Rivastigmine—Alzheimer's disease	9.97e-05	0.000702	CcSEcCtD
Memantine—Rhinitis—Donepezil—Alzheimer's disease	9.95e-05	0.000701	CcSEcCtD
Memantine—Hyperglycaemia—Rivastigmine—Alzheimer's disease	9.94e-05	0.0007	CcSEcCtD
Memantine—Haemorrhage—Donepezil—Alzheimer's disease	9.93e-05	0.0007	CcSEcCtD
Memantine—Hepatitis—Donepezil—Alzheimer's disease	9.93e-05	0.0007	CcSEcCtD
Memantine—Pneumonia—Rivastigmine—Alzheimer's disease	9.88e-05	0.000696	CcSEcCtD
Memantine—Hallucination—Donepezil—Alzheimer's disease	9.88e-05	0.000696	CcSEcCtD
Memantine—Hypoaesthesia—Donepezil—Alzheimer's disease	9.88e-05	0.000696	CcSEcCtD
Memantine—Palpitations—Galantamine—Alzheimer's disease	9.86e-05	0.000695	CcSEcCtD
Memantine—Pharyngitis—Donepezil—Alzheimer's disease	9.85e-05	0.000694	CcSEcCtD
Memantine—Infestation—Rivastigmine—Alzheimer's disease	9.82e-05	0.000692	CcSEcCtD
Memantine—Infestation NOS—Rivastigmine—Alzheimer's disease	9.82e-05	0.000692	CcSEcCtD
Memantine—Urinary tract disorder—Donepezil—Alzheimer's disease	9.81e-05	0.000691	CcSEcCtD
Memantine—Loss of consciousness—Galantamine—Alzheimer's disease	9.8e-05	0.000691	CcSEcCtD
Memantine—Depression—Rivastigmine—Alzheimer's disease	9.8e-05	0.00069	CcSEcCtD
Memantine—Oedema peripheral—Donepezil—Alzheimer's disease	9.78e-05	0.000689	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	9.74e-05	0.000686	CcSEcCtD
Memantine—Urethral disorder—Donepezil—Alzheimer's disease	9.73e-05	0.000686	CcSEcCtD
Memantine—Cough—Galantamine—Alzheimer's disease	9.73e-05	0.000686	CcSEcCtD
Memantine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	9.68e-05	0.000682	CcSEcCtD
Memantine—Convulsion—Galantamine—Alzheimer's disease	9.66e-05	0.000681	CcSEcCtD
Memantine—Renal failure—Rivastigmine—Alzheimer's disease	9.66e-05	0.000681	CcSEcCtD
Memantine—Myocardial infarction—Rivastigmine—Alzheimer's disease	9.63e-05	0.000679	CcSEcCtD
Memantine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	9.63e-05	0.000679	CcSEcCtD
Memantine—Hypertension—Galantamine—Alzheimer's disease	9.63e-05	0.000679	CcSEcCtD
Memantine—Visual impairment—Donepezil—Alzheimer's disease	9.57e-05	0.000674	CcSEcCtD
Memantine—Urinary tract infection—Rivastigmine—Alzheimer's disease	9.55e-05	0.000673	CcSEcCtD
Memantine—Conjunctivitis—Rivastigmine—Alzheimer's disease	9.55e-05	0.000673	CcSEcCtD
Memantine—Chest pain—Galantamine—Alzheimer's disease	9.49e-05	0.000669	CcSEcCtD
Memantine—Myalgia—Galantamine—Alzheimer's disease	9.49e-05	0.000669	CcSEcCtD
Memantine—Arthralgia—Galantamine—Alzheimer's disease	9.49e-05	0.000669	CcSEcCtD
Memantine—Anxiety—Galantamine—Alzheimer's disease	9.46e-05	0.000667	CcSEcCtD
Memantine—Discomfort—Galantamine—Alzheimer's disease	9.38e-05	0.000661	CcSEcCtD
Memantine—Haematuria—Rivastigmine—Alzheimer's disease	9.37e-05	0.00066	CcSEcCtD
Memantine—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	9.29e-05	0.000655	CcSEcCtD
Memantine—Dry mouth—Galantamine—Alzheimer's disease	9.29e-05	0.000654	CcSEcCtD
Memantine—Epistaxis—Rivastigmine—Alzheimer's disease	9.27e-05	0.000653	CcSEcCtD
Memantine—Tinnitus—Donepezil—Alzheimer's disease	9.26e-05	0.000652	CcSEcCtD
Memantine—Sinusitis—Rivastigmine—Alzheimer's disease	9.22e-05	0.00065	CcSEcCtD
Memantine—Confusional state—Galantamine—Alzheimer's disease	9.18e-05	0.000647	CcSEcCtD
Memantine—Bradycardia—Rivastigmine—Alzheimer's disease	8.98e-05	0.000633	CcSEcCtD
Memantine—Shock—Galantamine—Alzheimer's disease	8.95e-05	0.000631	CcSEcCtD
Memantine—Nervous system disorder—Galantamine—Alzheimer's disease	8.93e-05	0.000629	CcSEcCtD
Memantine—Thrombocytopenia—Galantamine—Alzheimer's disease	8.91e-05	0.000628	CcSEcCtD
Memantine—Chills—Donepezil—Alzheimer's disease	8.91e-05	0.000628	CcSEcCtD
Memantine—Tachycardia—Galantamine—Alzheimer's disease	8.88e-05	0.000626	CcSEcCtD
Memantine—Arrhythmia—Donepezil—Alzheimer's disease	8.87e-05	0.000625	CcSEcCtD
Memantine—Haemoglobin—Rivastigmine—Alzheimer's disease	8.86e-05	0.000625	CcSEcCtD
Memantine—Rhinitis—Rivastigmine—Alzheimer's disease	8.84e-05	0.000623	CcSEcCtD
Memantine—Skin disorder—Galantamine—Alzheimer's disease	8.84e-05	0.000623	CcSEcCtD
Memantine—Hepatitis—Rivastigmine—Alzheimer's disease	8.82e-05	0.000622	CcSEcCtD
Memantine—Haemorrhage—Rivastigmine—Alzheimer's disease	8.82e-05	0.000622	CcSEcCtD
Memantine—Hyperhidrosis—Galantamine—Alzheimer's disease	8.8e-05	0.00062	CcSEcCtD
Memantine—Hallucination—Rivastigmine—Alzheimer's disease	8.77e-05	0.000618	CcSEcCtD
Memantine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	8.77e-05	0.000618	CcSEcCtD
Memantine—Alopecia—Donepezil—Alzheimer's disease	8.77e-05	0.000618	CcSEcCtD
Memantine—Pharyngitis—Rivastigmine—Alzheimer's disease	8.75e-05	0.000617	CcSEcCtD
Memantine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	8.71e-05	0.000614	CcSEcCtD
Memantine—Mental disorder—Donepezil—Alzheimer's disease	8.7e-05	0.000613	CcSEcCtD
Memantine—Oedema peripheral—Rivastigmine—Alzheimer's disease	8.69e-05	0.000612	CcSEcCtD
Memantine—Anorexia—Galantamine—Alzheimer's disease	8.68e-05	0.000611	CcSEcCtD
Memantine—Connective tissue disorder—Rivastigmine—Alzheimer's disease	8.67e-05	0.000611	CcSEcCtD
Memantine—Urethral disorder—Rivastigmine—Alzheimer's disease	8.65e-05	0.000609	CcSEcCtD
Memantine—Malnutrition—Donepezil—Alzheimer's disease	8.64e-05	0.000609	CcSEcCtD
Memantine—Flatulence—Donepezil—Alzheimer's disease	8.52e-05	0.0006	CcSEcCtD
Memantine—Hypotension—Galantamine—Alzheimer's disease	8.51e-05	0.000599	CcSEcCtD
Memantine—Visual impairment—Rivastigmine—Alzheimer's disease	8.5e-05	0.000599	CcSEcCtD
Memantine—Tension—Donepezil—Alzheimer's disease	8.48e-05	0.000598	CcSEcCtD
Memantine—Dysgeusia—Donepezil—Alzheimer's disease	8.46e-05	0.000596	CcSEcCtD
Memantine—Nervousness—Donepezil—Alzheimer's disease	8.39e-05	0.000592	CcSEcCtD
Memantine—Back pain—Donepezil—Alzheimer's disease	8.36e-05	0.000589	CcSEcCtD
Memantine—Erythema multiforme—Rivastigmine—Alzheimer's disease	8.34e-05	0.000588	CcSEcCtD
Memantine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	8.29e-05	0.000584	CcSEcCtD
Memantine—Eye disorder—Rivastigmine—Alzheimer's disease	8.24e-05	0.000581	CcSEcCtD
Memantine—Insomnia—Galantamine—Alzheimer's disease	8.23e-05	0.00058	CcSEcCtD
Memantine—Tinnitus—Rivastigmine—Alzheimer's disease	8.22e-05	0.000579	CcSEcCtD
Memantine—Cardiac disorder—Rivastigmine—Alzheimer's disease	8.18e-05	0.000577	CcSEcCtD
Memantine—Flushing—Rivastigmine—Alzheimer's disease	8.18e-05	0.000577	CcSEcCtD
Memantine—Paraesthesia—Galantamine—Alzheimer's disease	8.17e-05	0.000576	CcSEcCtD
Memantine—Vision blurred—Donepezil—Alzheimer's disease	8.15e-05	0.000574	CcSEcCtD
Memantine—Tremor—Donepezil—Alzheimer's disease	8.1e-05	0.000571	CcSEcCtD
Memantine—Somnolence—Galantamine—Alzheimer's disease	8.09e-05	0.00057	CcSEcCtD
Memantine—Ill-defined disorder—Donepezil—Alzheimer's disease	8.02e-05	0.000565	CcSEcCtD
Memantine—Dyspepsia—Galantamine—Alzheimer's disease	8.01e-05	0.000565	CcSEcCtD
Memantine—Angiopathy—Rivastigmine—Alzheimer's disease	8e-05	0.000564	CcSEcCtD
Memantine—Anaemia—Donepezil—Alzheimer's disease	7.99e-05	0.000563	CcSEcCtD
Memantine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	7.95e-05	0.00056	CcSEcCtD
Memantine—Agitation—Donepezil—Alzheimer's disease	7.94e-05	0.00056	CcSEcCtD
Memantine—Chills—Rivastigmine—Alzheimer's disease	7.91e-05	0.000558	CcSEcCtD
Memantine—Decreased appetite—Galantamine—Alzheimer's disease	7.91e-05	0.000558	CcSEcCtD
Memantine—Arrhythmia—Rivastigmine—Alzheimer's disease	7.88e-05	0.000555	CcSEcCtD
Memantine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	7.86e-05	0.000554	CcSEcCtD
Memantine—Fatigue—Galantamine—Alzheimer's disease	7.85e-05	0.000553	CcSEcCtD
Memantine—Malaise—Donepezil—Alzheimer's disease	7.79e-05	0.000549	CcSEcCtD
Memantine—Alopecia—Rivastigmine—Alzheimer's disease	7.79e-05	0.000549	CcSEcCtD
Memantine—Constipation—Galantamine—Alzheimer's disease	7.78e-05	0.000549	CcSEcCtD
Memantine—Vertigo—Donepezil—Alzheimer's disease	7.77e-05	0.000547	CcSEcCtD
Memantine—Syncope—Donepezil—Alzheimer's disease	7.75e-05	0.000546	CcSEcCtD
Memantine—Mental disorder—Rivastigmine—Alzheimer's disease	7.73e-05	0.000545	CcSEcCtD
Memantine—Malnutrition—Rivastigmine—Alzheimer's disease	7.68e-05	0.000541	CcSEcCtD
Memantine—Loss of consciousness—Donepezil—Alzheimer's disease	7.6e-05	0.000535	CcSEcCtD
Memantine—Flatulence—Rivastigmine—Alzheimer's disease	7.56e-05	0.000533	CcSEcCtD
Memantine—Cough—Donepezil—Alzheimer's disease	7.54e-05	0.000532	CcSEcCtD
Memantine—Tension—Rivastigmine—Alzheimer's disease	7.53e-05	0.000531	CcSEcCtD
Memantine—Dysgeusia—Rivastigmine—Alzheimer's disease	7.52e-05	0.00053	CcSEcCtD
Memantine—Feeling abnormal—Galantamine—Alzheimer's disease	7.5e-05	0.000529	CcSEcCtD
Memantine—Convulsion—Donepezil—Alzheimer's disease	7.49e-05	0.000528	CcSEcCtD
Memantine—Hypertension—Donepezil—Alzheimer's disease	7.46e-05	0.000526	CcSEcCtD
Memantine—Nervousness—Rivastigmine—Alzheimer's disease	7.46e-05	0.000525	CcSEcCtD
Memantine—Gastrointestinal pain—Galantamine—Alzheimer's disease	7.44e-05	0.000525	CcSEcCtD
Memantine—Back pain—Rivastigmine—Alzheimer's disease	7.43e-05	0.000523	CcSEcCtD
Memantine—Myalgia—Donepezil—Alzheimer's disease	7.36e-05	0.000519	CcSEcCtD
Memantine—Chest pain—Donepezil—Alzheimer's disease	7.36e-05	0.000519	CcSEcCtD
Memantine—Arthralgia—Donepezil—Alzheimer's disease	7.36e-05	0.000519	CcSEcCtD
Memantine—Anxiety—Donepezil—Alzheimer's disease	7.33e-05	0.000517	CcSEcCtD
Memantine—Discomfort—Donepezil—Alzheimer's disease	7.27e-05	0.000512	CcSEcCtD
Memantine—Vision blurred—Rivastigmine—Alzheimer's disease	7.24e-05	0.00051	CcSEcCtD
Memantine—Dry mouth—Donepezil—Alzheimer's disease	7.2e-05	0.000507	CcSEcCtD
Memantine—Abdominal pain—Galantamine—Alzheimer's disease	7.2e-05	0.000507	CcSEcCtD
Memantine—Body temperature increased—Galantamine—Alzheimer's disease	7.2e-05	0.000507	CcSEcCtD
Memantine—Tremor—Rivastigmine—Alzheimer's disease	7.19e-05	0.000507	CcSEcCtD
Memantine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	7.12e-05	0.000502	CcSEcCtD
Memantine—Confusional state—Donepezil—Alzheimer's disease	7.11e-05	0.000501	CcSEcCtD
Memantine—Anaemia—Rivastigmine—Alzheimer's disease	7.1e-05	0.0005	CcSEcCtD
Memantine—Agitation—Rivastigmine—Alzheimer's disease	7.06e-05	0.000497	CcSEcCtD
Memantine—Oedema—Donepezil—Alzheimer's disease	7.05e-05	0.000497	CcSEcCtD
Memantine—Infection—Donepezil—Alzheimer's disease	7.01e-05	0.000494	CcSEcCtD
Memantine—Shock—Donepezil—Alzheimer's disease	6.94e-05	0.000489	CcSEcCtD
Memantine—Malaise—Rivastigmine—Alzheimer's disease	6.92e-05	0.000488	CcSEcCtD
Memantine—Nervous system disorder—Donepezil—Alzheimer's disease	6.92e-05	0.000488	CcSEcCtD
Memantine—Thrombocytopenia—Donepezil—Alzheimer's disease	6.91e-05	0.000487	CcSEcCtD
Memantine—Vertigo—Rivastigmine—Alzheimer's disease	6.9e-05	0.000486	CcSEcCtD
Memantine—Syncope—Rivastigmine—Alzheimer's disease	6.88e-05	0.000485	CcSEcCtD
Memantine—Hyperhidrosis—Donepezil—Alzheimer's disease	6.82e-05	0.000481	CcSEcCtD
Memantine—Palpitations—Rivastigmine—Alzheimer's disease	6.78e-05	0.000478	CcSEcCtD
Memantine—Loss of consciousness—Rivastigmine—Alzheimer's disease	6.75e-05	0.000476	CcSEcCtD
Memantine—Anorexia—Donepezil—Alzheimer's disease	6.72e-05	0.000474	CcSEcCtD
Memantine—Hypersensitivity—Galantamine—Alzheimer's disease	6.71e-05	0.000473	CcSEcCtD
Memantine—Cough—Rivastigmine—Alzheimer's disease	6.7e-05	0.000472	CcSEcCtD
Memantine—Convulsion—Rivastigmine—Alzheimer's disease	6.65e-05	0.000469	CcSEcCtD
Memantine—Hypertension—Rivastigmine—Alzheimer's disease	6.63e-05	0.000467	CcSEcCtD
Memantine—Hypotension—Donepezil—Alzheimer's disease	6.59e-05	0.000465	CcSEcCtD
Memantine—Chest pain—Rivastigmine—Alzheimer's disease	6.54e-05	0.000461	CcSEcCtD
Memantine—Myalgia—Rivastigmine—Alzheimer's disease	6.54e-05	0.000461	CcSEcCtD
Memantine—Arthralgia—Rivastigmine—Alzheimer's disease	6.54e-05	0.000461	CcSEcCtD
Memantine—Asthenia—Galantamine—Alzheimer's disease	6.53e-05	0.00046	CcSEcCtD
Memantine—Anxiety—Rivastigmine—Alzheimer's disease	6.51e-05	0.000459	CcSEcCtD
Memantine—Discomfort—Rivastigmine—Alzheimer's disease	6.46e-05	0.000455	CcSEcCtD
Memantine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	6.43e-05	0.000453	CcSEcCtD
Memantine—Dry mouth—Rivastigmine—Alzheimer's disease	6.39e-05	0.00045	CcSEcCtD
Memantine—Insomnia—Donepezil—Alzheimer's disease	6.38e-05	0.00045	CcSEcCtD
Memantine—Paraesthesia—Donepezil—Alzheimer's disease	6.33e-05	0.000446	CcSEcCtD
Memantine—Confusional state—Rivastigmine—Alzheimer's disease	6.32e-05	0.000445	CcSEcCtD
Memantine—Dyspnoea—Donepezil—Alzheimer's disease	6.29e-05	0.000443	CcSEcCtD
Memantine—Somnolence—Donepezil—Alzheimer's disease	6.27e-05	0.000442	CcSEcCtD
Memantine—Oedema—Rivastigmine—Alzheimer's disease	6.27e-05	0.000442	CcSEcCtD
Memantine—Diarrhoea—Galantamine—Alzheimer's disease	6.23e-05	0.000439	CcSEcCtD
Memantine—Infection—Rivastigmine—Alzheimer's disease	6.22e-05	0.000439	CcSEcCtD
Memantine—Dyspepsia—Donepezil—Alzheimer's disease	6.21e-05	0.000438	CcSEcCtD
Memantine—Shock—Rivastigmine—Alzheimer's disease	6.16e-05	0.000434	CcSEcCtD
Memantine—Nervous system disorder—Rivastigmine—Alzheimer's disease	6.14e-05	0.000433	CcSEcCtD
Memantine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	6.13e-05	0.000432	CcSEcCtD
Memantine—Decreased appetite—Donepezil—Alzheimer's disease	6.13e-05	0.000432	CcSEcCtD
Memantine—Tachycardia—Rivastigmine—Alzheimer's disease	6.12e-05	0.000431	CcSEcCtD
Memantine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	6.09e-05	0.000429	CcSEcCtD
Memantine—Skin disorder—Rivastigmine—Alzheimer's disease	6.09e-05	0.000429	CcSEcCtD
Memantine—Fatigue—Donepezil—Alzheimer's disease	6.08e-05	0.000429	CcSEcCtD
Memantine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	6.06e-05	0.000427	CcSEcCtD
Memantine—Pain—Donepezil—Alzheimer's disease	6.03e-05	0.000425	CcSEcCtD
Memantine—Constipation—Donepezil—Alzheimer's disease	6.03e-05	0.000425	CcSEcCtD
Memantine—Dizziness—Galantamine—Alzheimer's disease	6.02e-05	0.000424	CcSEcCtD
Memantine—Anorexia—Rivastigmine—Alzheimer's disease	5.97e-05	0.000421	CcSEcCtD
Memantine—Hypotension—Rivastigmine—Alzheimer's disease	5.85e-05	0.000413	CcSEcCtD
Memantine—Feeling abnormal—Donepezil—Alzheimer's disease	5.81e-05	0.00041	CcSEcCtD
Memantine—Vomiting—Galantamine—Alzheimer's disease	5.79e-05	0.000408	CcSEcCtD
Memantine—Gastrointestinal pain—Donepezil—Alzheimer's disease	5.77e-05	0.000406	CcSEcCtD
Memantine—Rash—Galantamine—Alzheimer's disease	5.74e-05	0.000404	CcSEcCtD
Memantine—Dermatitis—Galantamine—Alzheimer's disease	5.73e-05	0.000404	CcSEcCtD
Memantine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	5.71e-05	0.000402	CcSEcCtD
Memantine—Headache—Galantamine—Alzheimer's disease	5.7e-05	0.000402	CcSEcCtD
Memantine—Insomnia—Rivastigmine—Alzheimer's disease	5.67e-05	0.000399	CcSEcCtD
Memantine—Paraesthesia—Rivastigmine—Alzheimer's disease	5.63e-05	0.000396	CcSEcCtD
Memantine—Urticaria—Donepezil—Alzheimer's disease	5.6e-05	0.000395	CcSEcCtD
Memantine—Dyspnoea—Rivastigmine—Alzheimer's disease	5.59e-05	0.000394	CcSEcCtD
Memantine—Abdominal pain—Donepezil—Alzheimer's disease	5.58e-05	0.000393	CcSEcCtD
Memantine—Body temperature increased—Donepezil—Alzheimer's disease	5.58e-05	0.000393	CcSEcCtD
Memantine—Somnolence—Rivastigmine—Alzheimer's disease	5.57e-05	0.000393	CcSEcCtD
Memantine—Dyspepsia—Rivastigmine—Alzheimer's disease	5.52e-05	0.000389	CcSEcCtD
Memantine—Decreased appetite—Rivastigmine—Alzheimer's disease	5.45e-05	0.000384	CcSEcCtD
Memantine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	5.41e-05	0.000381	CcSEcCtD
Memantine—Nausea—Galantamine—Alzheimer's disease	5.41e-05	0.000381	CcSEcCtD
Memantine—Fatigue—Rivastigmine—Alzheimer's disease	5.4e-05	0.000381	CcSEcCtD
Memantine—Constipation—Rivastigmine—Alzheimer's disease	5.36e-05	0.000378	CcSEcCtD
Memantine—Pain—Rivastigmine—Alzheimer's disease	5.36e-05	0.000378	CcSEcCtD
Memantine—Hypersensitivity—Donepezil—Alzheimer's disease	5.2e-05	0.000366	CcSEcCtD
Memantine—Feeling abnormal—Rivastigmine—Alzheimer's disease	5.16e-05	0.000364	CcSEcCtD
Memantine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	5.12e-05	0.000361	CcSEcCtD
Memantine—Asthenia—Donepezil—Alzheimer's disease	5.06e-05	0.000357	CcSEcCtD
Memantine—Pruritus—Donepezil—Alzheimer's disease	4.99e-05	0.000352	CcSEcCtD
Memantine—Urticaria—Rivastigmine—Alzheimer's disease	4.98e-05	0.000351	CcSEcCtD
Memantine—Abdominal pain—Rivastigmine—Alzheimer's disease	4.95e-05	0.000349	CcSEcCtD
Memantine—Body temperature increased—Rivastigmine—Alzheimer's disease	4.95e-05	0.000349	CcSEcCtD
Memantine—Diarrhoea—Donepezil—Alzheimer's disease	4.83e-05	0.00034	CcSEcCtD
Memantine—Dizziness—Donepezil—Alzheimer's disease	4.66e-05	0.000329	CcSEcCtD
Memantine—Hypersensitivity—Rivastigmine—Alzheimer's disease	4.62e-05	0.000325	CcSEcCtD
Memantine—Asthenia—Rivastigmine—Alzheimer's disease	4.5e-05	0.000317	CcSEcCtD
Memantine—Vomiting—Donepezil—Alzheimer's disease	4.48e-05	0.000316	CcSEcCtD
Memantine—Rash—Donepezil—Alzheimer's disease	4.45e-05	0.000313	CcSEcCtD
Memantine—Dermatitis—Donepezil—Alzheimer's disease	4.44e-05	0.000313	CcSEcCtD
Memantine—Pruritus—Rivastigmine—Alzheimer's disease	4.43e-05	0.000312	CcSEcCtD
Memantine—Headache—Donepezil—Alzheimer's disease	4.42e-05	0.000311	CcSEcCtD
Memantine—Diarrhoea—Rivastigmine—Alzheimer's disease	4.29e-05	0.000302	CcSEcCtD
Memantine—Nausea—Donepezil—Alzheimer's disease	4.19e-05	0.000295	CcSEcCtD
Memantine—Dizziness—Rivastigmine—Alzheimer's disease	4.14e-05	0.000292	CcSEcCtD
Memantine—Vomiting—Rivastigmine—Alzheimer's disease	3.98e-05	0.000281	CcSEcCtD
Memantine—Rash—Rivastigmine—Alzheimer's disease	3.95e-05	0.000278	CcSEcCtD
Memantine—Dermatitis—Rivastigmine—Alzheimer's disease	3.95e-05	0.000278	CcSEcCtD
Memantine—Headache—Rivastigmine—Alzheimer's disease	3.93e-05	0.000277	CcSEcCtD
Memantine—Nausea—Rivastigmine—Alzheimer's disease	3.72e-05	0.000262	CcSEcCtD
Memantine—DRD2—Signaling by GPCR—CDK5—Alzheimer's disease	1.38e-05	0.00018	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ND1—Alzheimer's disease	1.35e-05	0.000177	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—HSD17B10—Alzheimer's disease	1.34e-05	0.000174	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HTR6—Alzheimer's disease	1.33e-05	0.000173	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CA4—Alzheimer's disease	1.32e-05	0.000173	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—VEGFA—Alzheimer's disease	1.3e-05	0.000169	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP46A1—Alzheimer's disease	1.29e-05	0.000168	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—VEGFA—Alzheimer's disease	1.26e-05	0.000165	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	1.25e-05	0.000162	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GAPDHS—Alzheimer's disease	1.24e-05	0.000162	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ND1—Alzheimer's disease	1.24e-05	0.000162	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	1.22e-05	0.000159	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—GAL—Alzheimer's disease	1.21e-05	0.000158	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—CREB1—Alzheimer's disease	1.21e-05	0.000158	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ATP5A1—Alzheimer's disease	1.18e-05	0.000154	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—DHCR24—Alzheimer's disease	1.18e-05	0.000153	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PLD3—Alzheimer's disease	1.13e-05	0.000147	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GAL—Alzheimer's disease	1.1e-05	0.000144	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	1.1e-05	0.000143	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—HSD17B10—Alzheimer's disease	1.08e-05	0.000141	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—TGFB1—Alzheimer's disease	1.07e-05	0.00014	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TTR—Alzheimer's disease	1.07e-05	0.00014	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	1.07e-05	0.000139	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP46A1—Alzheimer's disease	1.04e-05	0.000135	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ND1—Alzheimer's disease	1e-05	0.000131	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CA4—Alzheimer's disease	1e-05	0.00013	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	9.87e-06	0.000129	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	9.77e-06	0.000127	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—NPY—Alzheimer's disease	9.53e-06	0.000124	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	9.52e-06	0.000124	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CCR5—Alzheimer's disease	9.49e-06	0.000124	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—IAPP—Alzheimer's disease	9.47e-06	0.000124	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—MAPK8—Alzheimer's disease	9.44e-06	0.000123	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GAPDHS—Alzheimer's disease	9.4e-06	0.000123	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PYY—Alzheimer's disease	9.39e-06	0.000123	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—HTR2A—Alzheimer's disease	9.28e-06	0.000121	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—VEGFA—Alzheimer's disease	9.25e-06	0.000121	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CRH—Alzheimer's disease	9.2e-06	0.00012	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—VEGFA—Alzheimer's disease	9.02e-06	0.000118	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—IL6—Alzheimer's disease	8.97e-06	0.000117	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ATP5A1—Alzheimer's disease	8.91e-06	0.000116	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—IL6—Alzheimer's disease	8.74e-06	0.000114	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CHAT—Alzheimer's disease	8.72e-06	0.000114	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TPI1—Alzheimer's disease	8.72e-06	0.000114	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—NPS—Alzheimer's disease	8.72e-06	0.000114	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—NPY—Alzheimer's disease	8.66e-06	0.000113	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IAPP—Alzheimer's disease	8.6e-06	0.000112	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PLD3—Alzheimer's disease	8.5e-06	0.000111	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	8.5e-06	0.000111	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TGFB1—Alzheimer's disease	8.49e-06	0.000111	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	8.4e-06	0.00011	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—MAOB—Alzheimer's disease	8.36e-06	0.000109	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CRH—Alzheimer's disease	8.35e-06	0.000109	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—SST—Alzheimer's disease	8.32e-06	0.000108	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—GAB2—Alzheimer's disease	8.32e-06	0.000108	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TGFB1—Alzheimer's disease	8.28e-06	0.000108	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HSD17B10—Alzheimer's disease	8.15e-06	0.000106	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDK5—Alzheimer's disease	8.14e-06	0.000106	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—F2—Alzheimer's disease	8.14e-06	0.000106	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—APP—Alzheimer's disease	8.11e-06	0.000106	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GAPDH—Alzheimer's disease	8.05e-06	0.000105	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CHAT—Alzheimer's disease	8.01e-06	0.000104	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TPI1—Alzheimer's disease	8.01e-06	0.000104	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	7.97e-06	0.000104	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TNF—Alzheimer's disease	7.93e-06	0.000103	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—NPS—Alzheimer's disease	7.92e-06	0.000103	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PPP3CA—Alzheimer's disease	7.88e-06	0.000103	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	7.85e-06	0.000102	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HTR6—Alzheimer's disease	7.84e-06	0.000102	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—A2M—Alzheimer's disease	7.78e-06	0.000101	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TNF—Alzheimer's disease	7.73e-06	0.000101	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—MAOB—Alzheimer's disease	7.68e-06	0.0001	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PLCB1—Alzheimer's disease	7.65e-06	9.98e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ND1—Alzheimer's disease	7.58e-06	9.88e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GAB2—Alzheimer's disease	7.55e-06	9.85e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—SST—Alzheimer's disease	7.55e-06	9.85e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	7.41e-06	9.66e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GAPDH—Alzheimer's disease	7.39e-06	9.64e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—APP—Alzheimer's disease	7.36e-06	9.6e-05	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CCL2—Alzheimer's disease	7.25e-06	9.46e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—A2M—Alzheimer's disease	7.14e-06	9.31e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PSENEN—Alzheimer's disease	7.12e-06	9.28e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APH1A—Alzheimer's disease	7.02e-06	9.16e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PLCB1—Alzheimer's disease	6.95e-06	9.06e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NCSTN—Alzheimer's disease	6.83e-06	8.91e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	6.77e-06	8.83e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ACHE—Alzheimer's disease	6.76e-06	8.82e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—INPP5D—Alzheimer's disease	6.69e-06	8.72e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—LRP1—Alzheimer's disease	6.67e-06	8.69e-05	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—Alzheimer's disease	6.59e-06	8.59e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GFAP—Alzheimer's disease	6.51e-06	8.49e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GAL—Alzheimer's disease	6.51e-06	8.49e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TPI1—Alzheimer's disease	6.46e-06	8.43e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CHAT—Alzheimer's disease	6.46e-06	8.43e-05	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—IL6—Alzheimer's disease	6.4e-06	8.35e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ENO1—Alzheimer's disease	6.34e-06	8.27e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS1—Alzheimer's disease	6.34e-06	8.27e-05	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—IL6—Alzheimer's disease	6.24e-06	8.14e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP2D6—Alzheimer's disease	6.22e-06	8.11e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ACHE—Alzheimer's disease	6.21e-06	8.1e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—MAOB—Alzheimer's disease	6.19e-06	8.08e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—INPP5D—Alzheimer's disease	6.14e-06	8.01e-05	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—IL6—Alzheimer's disease	6.03e-06	7.86e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GAPDH—Alzheimer's disease	5.96e-06	7.78e-05	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—AKT1—Alzheimer's disease	5.9e-06	7.7e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—BCHE—Alzheimer's disease	5.89e-06	7.69e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	5.84e-06	7.61e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS1—Alzheimer's disease	5.82e-06	7.59e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ENO1—Alzheimer's disease	5.82e-06	7.59e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—A2M—Alzheimer's disease	5.76e-06	7.51e-05	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—AKT1—Alzheimer's disease	5.76e-06	7.51e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—A2M—Alzheimer's disease	5.74e-06	7.48e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP2D6—Alzheimer's disease	5.71e-06	7.44e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PRKCG—Alzheimer's disease	5.66e-06	7.38e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PLCB1—Alzheimer's disease	5.56e-06	7.25e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PSEN2—Alzheimer's disease	5.56e-06	7.25e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—BCHE—Alzheimer's disease	5.41e-06	7.06e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ABCA1—Alzheimer's disease	5.39e-06	7.03e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CCR5—Alzheimer's disease	5.36e-06	6.99e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	5.32e-06	6.93e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—HTR2A—Alzheimer's disease	5.25e-06	6.84e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PRKCG—Alzheimer's disease	5.14e-06	6.7e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NPY—Alzheimer's disease	5.11e-06	6.67e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PLCB1—Alzheimer's disease	5.1e-06	6.66e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IAPP—Alzheimer's disease	5.08e-06	6.63e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ACHE—Alzheimer's disease	5.01e-06	6.53e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—INPP5D—Alzheimer's disease	4.95e-06	6.46e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ABCA1—Alzheimer's disease	4.95e-06	6.45e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CRH—Alzheimer's disease	4.93e-06	6.44e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TPI1—Alzheimer's disease	4.88e-06	6.37e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CHAT—Alzheimer's disease	4.88e-06	6.37e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCR5—Alzheimer's disease	4.87e-06	6.35e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HTR2A—Alzheimer's disease	4.76e-06	6.21e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ENO1—Alzheimer's disease	4.69e-06	6.12e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS1—Alzheimer's disease	4.69e-06	6.12e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—MAOB—Alzheimer's disease	4.68e-06	6.11e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NPS—Alzheimer's disease	4.68e-06	6.1e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PPP3CA—Alzheimer's disease	4.65e-06	6.07e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPARGC1A—Alzheimer's disease	4.65e-06	6.06e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—HMOX1—Alzheimer's disease	4.62e-06	6.03e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP2D6—Alzheimer's disease	4.6e-06	6.01e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—F2—Alzheimer's disease	4.6e-06	6e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTK2B—Alzheimer's disease	4.59e-06	5.98e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	4.51e-06	5.88e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SST—Alzheimer's disease	4.46e-06	5.82e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GAB2—Alzheimer's disease	4.46e-06	5.82e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NTRK2—Alzheimer's disease	4.46e-06	5.82e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	4.46e-06	5.81e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CALM1—Alzheimer's disease	4.44e-06	5.8e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GSK3A—Alzheimer's disease	4.42e-06	5.77e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	4.41e-06	5.76e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—BCHE—Alzheimer's disease	4.36e-06	5.69e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—A2M—Alzheimer's disease	4.35e-06	5.68e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APP—Alzheimer's disease	4.35e-06	5.67e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPARGC1A—Alzheimer's disease	4.26e-06	5.56e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—HMOX1—Alzheimer's disease	4.24e-06	5.54e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—LPL—Alzheimer's disease	4.23e-06	5.52e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—F2—Alzheimer's disease	4.18e-06	5.45e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PLCB1—Alzheimer's disease	4.12e-06	5.37e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PLCB1—Alzheimer's disease	4.1e-06	5.35e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ABCA1—Alzheimer's disease	3.99e-06	5.21e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—LPL—Alzheimer's disease	3.88e-06	5.06e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.88e-06	5.06e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NGFR—Alzheimer's disease	3.83e-06	4.99e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—MTHFR—Alzheimer's disease	3.81e-06	4.97e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CREB1—Alzheimer's disease	3.8e-06	4.96e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ACHE—Alzheimer's disease	3.79e-06	4.94e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	3.74e-06	4.88e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ADAM10—Alzheimer's disease	3.74e-06	4.88e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCL2—Alzheimer's disease	3.72e-06	4.86e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CALM1—Alzheimer's disease	3.56e-06	4.64e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ENO1—Alzheimer's disease	3.55e-06	4.63e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	3.55e-06	4.63e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—APOE—Alzheimer's disease	3.54e-06	4.62e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—S100B—Alzheimer's disease	3.54e-06	4.61e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CAV1—Alzheimer's disease	3.51e-06	4.58e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—MTHFR—Alzheimer's disease	3.5e-06	4.56e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	3.48e-06	4.54e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPARGC1A—Alzheimer's disease	3.44e-06	4.49e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—HMOX1—Alzheimer's disease	3.42e-06	4.47e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF2—Alzheimer's disease	3.37e-06	4.39e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—BCHE—Alzheimer's disease	3.3e-06	4.3e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CALM1—Alzheimer's disease	3.27e-06	4.26e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF1R—Alzheimer's disease	3.26e-06	4.25e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—APOE—Alzheimer's disease	3.25e-06	4.24e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CAV1—Alzheimer's disease	3.22e-06	4.21e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—LPL—Alzheimer's disease	3.13e-06	4.09e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—LPL—Alzheimer's disease	3.12e-06	4.07e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	3.11e-06	4.06e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MEF2C—Alzheimer's disease	3.09e-06	4.03e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPARG—Alzheimer's disease	3.09e-06	4.03e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.05e-06	3.98e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PRKCG—Alzheimer's disease	3.03e-06	3.96e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—INS—Alzheimer's disease	3.03e-06	3.95e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	3.02e-06	3.93e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NGF—Alzheimer's disease	2.96e-06	3.86e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCR5—Alzheimer's disease	2.88e-06	3.75e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPARG—Alzheimer's disease	2.83e-06	3.7e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—MTHFR—Alzheimer's disease	2.82e-06	3.68e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HTR2A—Alzheimer's disease	2.81e-06	3.67e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—INS—Alzheimer's disease	2.78e-06	3.63e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NOS3—Alzheimer's disease	2.66e-06	3.46e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CALM1—Alzheimer's disease	2.63e-06	3.44e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—APOE—Alzheimer's disease	2.63e-06	3.42e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CALM1—Alzheimer's disease	2.63e-06	3.42e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APOE—Alzheimer's disease	2.62e-06	3.41e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—LEP—Alzheimer's disease	2.62e-06	3.41e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CAV1—Alzheimer's disease	2.6e-06	3.39e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	2.6e-06	3.39e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CAV1—Alzheimer's disease	2.59e-06	3.38e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	2.59e-06	3.38e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	2.5e-06	3.26e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—F2—Alzheimer's disease	2.47e-06	3.22e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NOS3—Alzheimer's disease	2.44e-06	3.18e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—Alzheimer's disease	2.43e-06	3.17e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	2.41e-06	3.15e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—LPL—Alzheimer's disease	2.37e-06	3.09e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPARG—Alzheimer's disease	2.29e-06	2.98e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	2.27e-06	2.96e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	2.25e-06	2.93e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—INS—Alzheimer's disease	2.24e-06	2.93e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—INS—Alzheimer's disease	2.23e-06	2.92e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—Alzheimer's disease	2.23e-06	2.91e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	2.2e-06	2.87e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	2.16e-06	2.82e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	2.13e-06	2.78e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	1.99e-06	2.6e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APOE—Alzheimer's disease	1.98e-06	2.59e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NOS3—Alzheimer's disease	1.97e-06	2.57e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	1.97e-06	2.56e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	1.96e-06	2.56e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	1.8e-06	2.35e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	1.73e-06	2.25e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—INS—Alzheimer's disease	1.7e-06	2.21e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	1.68e-06	2.19e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	1.66e-06	2.17e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	1.65e-06	2.16e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	1.53e-06	1.99e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	1.53e-06	1.99e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	1.49e-06	1.94e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.41e-06	1.84e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.36e-06	1.77e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.3e-06	1.69e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKT1—Alzheimer's disease	1.22e-06	1.59e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKT1—Alzheimer's disease	1.12e-06	1.46e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	1.07e-06	1.39e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	9.77e-07	1.27e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKT1—Alzheimer's disease	9.04e-07	1.18e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	9.01e-07	1.18e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	6.83e-07	8.91e-06	CbGpPWpGaD
